Samsara Vision

Samsara Vision, Inc. Formerly know as VisionCare Ophthalmic Technologies is a privately held specialty medical device company focused on developing, manufacturing, and marketing proprietary implantable ophthalmic devices. The company’s primary technology, the Implantable Miniature Telescope (IMT) by Isaac Lipshitz, is the first and only FDA-approved implantable device designed to improve vision and quality of life for individuals with advanced, irreversible age-related macular degeneration (AMD). Samsara Vision operates in the medical device market, specifically targeting patients with severe vision disorders that are otherwise untreatable. The business model revolves around extensive collaboration with healthcare providers, researchers, payers, and advocates to ensure the effective deployment and adoption of their technologies. Samsara Vision generates revenue through the sale of its IMT devices and related ophthalmic technologies, aiming to restore vision and enhance the daily lives of its patients. Keywords: Implantable Miniature Telescope, age-related macular degeneration, ophthalmic devices, vision restoration, FDA-approved, retinal disorders, medical device, quality of life, healthcare collaboration, proprietary technology.